e-learning
resources
Munich 2006
Sunday 03.09.2006
Epidemiology, rare tumors (2), miscellaneous
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
A. Hayretdag, E. Yilmaz, A. Akkoclu, A. Kargi (Izmir, Turkey)
Source:
Annual Congress 2006 - Epidemiology, rare tumors (2), miscellaneous
Session:
Epidemiology, rare tumors (2), miscellaneous
Session type:
E-Posters in free access
Number:
626
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hayretdag, E. Yilmaz, A. Akkoclu, A. Kargi (Izmir, Turkey). The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma. Eur Respir J 2006; 28: Suppl. 50, 626
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma
Source: Eur Respir J 2005; 26: Suppl. 49, 74s
Year: 2005
Thoracoscopy and malignant pleural mesothelioma
Source: ERS Course 2015
Year: 2015
Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017
Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006
Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004
Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015
Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012
Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020
Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006
Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
A rare case of malignant pleural mesothelioma presenting with multiple metastatic pulmonary nodules
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011
Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept